Related Experiment Video
Updated: Jun 16, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
[PSA and spironolactone]
S Rybikowski1, C Maurin, J Deturmeny
1Service d'urologie, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France. stanryb@free.fr
Abstract:
The spironolactone is a diuretic of potassium savings. It is also used in the treatment of the hirsutism for its antiandrogenic action. Its use and its effects on the patients affected by a prostate cancer are less known. We report the case of a 72-year-old man having a cancer of prostate which normalized its PSA after institution of a treatment by spironolactone for ascites. This patient had a biological recurrence of a prostate cancer, arisen 7 years later after a treatment by hormonal radiotherapy. Nine months after the implementation of the treatment by spironolactone, there were no clinical and biological signs of disease progress.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Thiazide-Class Diuretics
Drug Therapy
Antianxiety Medications
Lipid-Lowering Drugs: Statins and Miscellaneous Agents